The vascular stent market boasts diverse applications and essential features. Vascular stents find use in coronary arteries, peripheral arteries, and even the esophagus to maintain vessel patency and restore blood flow. They are often drug-eluting to prevent restenosis. Key features include biocompatibility, radiopacity for visibility under imaging, flexibility to adapt to vessel contours, and radial strength for support. Additionally, newer stent designs aim to reduce the risk of stent thrombosis, promote endothelialization, and enhance long-term patient outcomes in treating cardiovascular and other vascular diseases.
According to Data Bridge Market Research, the Global Vascular Stent Market is expected to reach a value of USD 13.44 billion by the year 2029, at a CAGR of 7.81% during the forecast period of 2022-2029.
“Government investments boost the market’s growth”
Government investments in healthcare are a pivotal driver for the vascular stent market. Increased public funding and initiatives in healthcare infrastructure enhance access to advanced medical treatments, including vascular stents. These investments foster innovation, improve patient care, and support the development of cutting-edge medical devices. Consequently, the vascular stent market experiences growth as healthcare systems are strengthened, leading to increased demand for stents and advancements in cardiovascular care.
What restraints the growth of the global vascular stent market?
“Stringent government regulations the market’s growth”
Stringent government regulations pose a significant restraint on the vascular stent market. While rules are essential for ensuring product safety and efficacy, they add complexity, cost, and time to the product development and approval processes. Manufacturers must invest heavily in compliance, which can hinder innovation and market entry. Consequently, these regulations can act as barriers to new entrants and slow the introduction of cutting-edge technologies and treatments in the vascular stent market.
Segmentation: Global Vascular Stent Market
The global vascular stent market is segmented on the basis of type, product, mode of delivery, materials, and end user.
- On the basis of type, the global vascular stent market is segmented into drug-eluting stents, bare-metal stents and bio absorbable stents.
- On the basis of product, the vascular stent market is segmented into coronary stents, peripheral stents, and evar stent grafts.
- On the basis of mode of delivery, the vascular stent market is segmented into balloon-expandable stents and self-expanding stents.
- On the basis of materials, the vascular stent market is segmented into metallic stents and other stents.
- On the basis of end user, the vascular stent market is segmented into hospitals and cardiac centres, ambulatory surgical centres, and others.
Regional Insights: North America dominates the Global Vascular Stent Market
North America's dominance in the vascular stent market is driven by the growing adoption of minimally or non-invasive surgical procedures. This trend aligns with patients' preferences for less invasive treatments. Additionally, the region benefits from the rapid technological advancements in the field, which enhance the efficacy of vascular stents. Consequently, North America is expected to maintain its leadership position in the global vascular stent market during the forecast period.
The Asia-Pacific region is poised for rapid growth in the vascular stent market, driven by a burgeoning elderly population requiring medical intervention. The increasing prevalence of vascular conditions in the aging demographic fuels the demand for vascular stents. As healthcare infrastructure and access to advanced treatments improve, Asia-Pacific is projected to experience substantial growth in the vascular stent market during the forecast period.
To know more about the study visit, https://www.databridgemarketresearch.com/es/reports/global-vascular-stent-market
Recent Developments
- Medtronic's leadership in the total bare-metal stent market is attributed to its significant presence in the high-value iliac and femoral-popliteal segments. This strategic positioning has allowed the company to capture a substantial market share by addressing critical vascular needs in these segments.
- W. L. Gore's VIABAHN portfolio dominates the high-value covered stent segment. While VIABAHN devices are priced slightly higher than competitors like iCast and Fluency, they offer unique features and quality, attracting a specific customer base seeking premium covered stents.
- Boston Scientific's prominence in the iliac and renal stent segments is supported by its Express LD iliac and Express SD stents. These stents are preferred choices for healthcare professionals, helping Boston Scientific establish a strong presence in these vital vascular segments and contributing to the company's market influence.
The Prominent Key Players Operating in the Global Vascular Stent Market Include:
- Medtronic (Ireland)
- BD (U.S.)
- Cordis. (U.S.)
- Abbott. (U.S.)
- Boston Scientific Corporation (U.S.)
- Cook (U.K.)
- Cardiovascular Systems, Inc. (U.S.)
- AngioDynamics. (U.S.)
- Edwards Lifesciences Corporation. (U.S.)
- Biosensors International Group, Ltd. (Singapore)
- W. L. Gore & Associates, Inc. (U.S.)
- Teleflex Incorporated. (U.S.)
- OrbusNeich Medical Company Limited (Hong Kong)
- Merit Medical Systems. (U.S.)
- Terumo Medical Corporation (Japan)
- B. Braun Melsungen AG (Germany)
- MicroPort Scientific Corporation (China)
- Lepu Medical Technology (Beijing)Co.,Ltd (China)
- Koninklijke Philips N.V. (Netherlands)
Above are the key players covered in the report, to know about more and exhaustive list of global vascular stent market companies contact, https://www.databridgemarketresearch.com/es/contact
Research Methodology: Global Vascular Stent Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
